U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
7488174881Evaluation of Intestinal Brush Border Enzyme Function in Critically Ill PatientsRecruitingNo Results AvailableCritical Illness|Septic Shock|SIRSProcedure: Gastroscopyhttps://ClinicalTrials.gov/show/NCT01585909
7488274882Self-Help Group for the Treatment of Hoarding DisorderRecruitingNo Results AvailableHoarding DisorderOther: Self-Help Grouphttps://ClinicalTrials.gov/show/NCT01585896
7488374883Self-Management Intervention for Breathlessness in Lung CancerRecruitingNo Results AvailableLung Cancer|BreathlessnessBehavioral: Self-management Interventionhttps://ClinicalTrials.gov/show/NCT01585883
7488474884Safety, Pharmacokinetics, Pharmacodynamics and Anti-tumor Activity of Sorafenib and Eribulin in CombinationActive, not recruitingNo Results AvailableNeoplasmsDrug: Sorafenib (Nexavar, BAY43-9006)|Drug: Eribulinhttps://ClinicalTrials.gov/show/NCT01585870
7488574885ADIPOA - Clinical StudyCompletedNo Results AvailableOsteoarthritisBiological: Autologous adipose derived stem cells administrated for intra-articular use|Biological: Autologous adipose derived stem cells administrated for intra-articular usehttps://ClinicalTrials.gov/show/NCT01585857
7488674886Sleep Apnea in Pregnancy Screening StudyCompletedNo Results AvailableSleep Apnea|Obesityhttps://ClinicalTrials.gov/show/NCT01585844
7488774887Study of Psychological and Motor Effects of Testosterone in Adolescents With XXY/Klinefelter SyndromeRecruitingNo Results AvailableKlinefelter Syndrome|XXY SyndromeDrug: Testosterone gel 1%|Drug: Placebo gelhttps://ClinicalTrials.gov/show/NCT01585831
7488874888Dietary Intervention in Diabetes Mellitus (DIDM)- Intermediate and Acute EffectsRecruitingNo Results AvailableType 2 Diabetes MellitusOther: Low Glycemic Index (LGI) intervention arm|Other: Standard Diet Interventionhttps://ClinicalTrials.gov/show/NCT01585818
7488974889Gemcitabine Hydrochloride and Cisplatin With or Without Veliparib or Veliparib Alone in Patients With Locally Advanced or Metastatic Pancreatic CancerRecruitingNo Results AvailableBRCA1 Mutation Carrier|BRCA2 Mutation Carrier|Pancreatic Adenocarcinoma|Recurrent Pancreatic Carcinoma|Stage III Pancreatic Cancer|Stage IV Pancreatic CancerDrug: Cisplatin|Drug: Gemcitabine Hydrochloride|Other: Laboratory Biomarker Analysis|Drug: Veliparibhttps://ClinicalTrials.gov/show/NCT01585805
7489074890Double Blind Comparative Study of TAK-875CompletedNo Results AvailableDiabetic PatientsDrug: TAK-875|Drug: TAK-875|Drug: Glimepiride|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01585792
7489174891Contour 3D®/Tri-Ad® Tricuspid Annuloplasty Ring Post-Market Clinical TrialActive, not recruitingNo Results AvailableTricuspid Valve Regurgitation|Tricuspid Valve InsufficiencyDevice: Contour 3D® or Tri-Ad® implant for tricuspid valve repairhttps://ClinicalTrials.gov/show/NCT01585779
7489274892Safety and Tolerability Study of MEDI-551, a B-cell Depleting Agent, to Treat Relapsing Forms of Multiple SclerosisActive, not recruitingNo Results AvailableMultiple Sclerosis, Relapsing FormsBiological: MEDI-551 IV|Biological: MEDI-551 SC|Drug: Placebo IV|Drug: Placebo SChttps://ClinicalTrials.gov/show/NCT01585766
7489374893MARCH Vascular Endothelium SubstudyActive, not recruitingNo Results AvailableCardiovascular DiseaseDrug: NRTI + PI|Drug: maraviroc + PI|Drug: maraviroc + NRTIhttps://ClinicalTrials.gov/show/NCT01585753
7489474894Ringer's Lactate Versus Normal Saline in Caesarean SectionCompletedNo Results AvailableNormal Anion Gap Metabolic AcidosisDrug: 0.9% Normal Saline|Drug: Ringer's Lactatehttps://ClinicalTrials.gov/show/NCT01585740
7489574895Intraoperative Monitoring of the Pelvic Autonomic NervesRecruitingNo Results AvailableRectal CancerProcedure: TME|Procedure: TME|Procedure: Neuromonitoringhttps://ClinicalTrials.gov/show/NCT01585727
7489674896Phase I Study of AT13148, a Novel AGC Kinase InhibitorRecruitingNo Results AvailableAdvanced Solid TumoursBiological: AT13148https://ClinicalTrials.gov/show/NCT01585701
7489774897Phase I/II Study of hLL1-DOX in Relapsed NHL and CLLActive, not recruitingNo Results AvailableNon-Hodgkin's Lymphoma|Chronic Lymphocytic LeukemiaDrug: hLL1-DOX (IMMU-115)https://ClinicalTrials.gov/show/NCT01585688
7489874898Specimen Banking From Patients With Lung CancerRecruitingNo Results AvailableLung Neoplasmshttps://ClinicalTrials.gov/show/NCT01585675
7489974899Prospective Random Comparing Study on EUS-guided Pseudocyst Drainage by Naso-pancreatic Tube and StentsRecruitingNo Results AvailablePancreatic PseudocystProcedure: EUS-guided pancreatic pseudocyst drainagehttps://ClinicalTrials.gov/show/NCT01585662
7490074900PK/PD of XM22 in Children With Ewing Family of Tumors or RhabdomyosarcomaCompletedNo Results AvailableEwing Family of Tumors, RhabdomyosarcomaDrug: Lipegfilgrastimhttps://ClinicalTrials.gov/show/NCT01585649
7490174901Escalating Single-dose Safety, Tolerability, and Pharmacokinetics of SQ109 in Healthy VolunteersCompletedNo Results AvailableTuberculosisDrug: SQ109https://ClinicalTrials.gov/show/NCT01585636
7490274902Drug Interaction Study of SAR302503 in Patients With Solid TumorCompletedNo Results AvailableSolid TumorDrug: SAR302503|Drug: omeprazol|Drug: metoprolol|Drug: midazolamhttps://ClinicalTrials.gov/show/NCT01585623
7490374903Motivating Smokers With Mobility Impairments to Quit SmokingActive, not recruitingNo Results AvailableSmokingBehavioral: DVD Intervention|Behavioral: Standard Care Printed Materialshttps://ClinicalTrials.gov/show/NCT01585610
7490474904Reperfusion With Cooling in Cerebral Acute IschemiaCompletedHas ResultsStroke, AcuteDevice: Zoll- Coolgaurd 3000https://ClinicalTrials.gov/show/NCT01585597
7490574905Triple-Therapy in Patients With HCV Genotype 3 Who Previously Failed TreatmentCompletedHas ResultsHepatitis CDrug: Boceprevirhttps://ClinicalTrials.gov/show/NCT01585584
7490674906Balance and Posture in Adults With Cerebral PalsyRecruitingNo Results AvailableCerebral Palsyhttps://ClinicalTrials.gov/show/NCT01585571
7490774907Long-Term Safety of 30 mg and 60 mg Oral Daily Dose of Ospemifene in the Treatment of Vulvar and Vaginal Atrophy (VVA) in Postmenopausal Women With Intact UterusCompletedHas ResultsAtrophy|Vaginal DiseasesDrug: Ospemifene (Dose 1)|Drug: Ospemifene (Dose 2)|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01585558
7490874908Radiogenomic Assessment in NSCLC: Correlation Between Multiparametric Imaging Biomarkers and Genetic BiomarkersRecruitingNo Results AvailableLung Cancerhttps://ClinicalTrials.gov/show/NCT01585545
7490974909Alere Mycobacterium Tuberculosis Urine StudyCompletedNo Results AvailableTuberculosishttps://ClinicalTrials.gov/show/NCT01585532
7491074910A Study Examining Effects of Apples/ Apple Products on Heart Disease RiskRecruitingNo Results AvailableCardiovascular DiseaseDietary Supplement: High/ Low Epicatechin Apples/ Apple Extract/ Granuleshttps://ClinicalTrials.gov/show/NCT01585519

* Görseller ve İçerik tekif hakkına sahip olabilir